Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

BACKGROUND: Adverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decreas...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Bioinformatics
Päätekijät: Wu, Leihong, Ingle, Taylor, Liu, Zhichao, Zhao-Wong, Anna, Harris, Stephen, Thakkar, Shraddha, Zhou, Guangxu, Yang, Junshuang, Xu, Joshua, Mehta, Darshan, Ge, Weigong, Tong, Weida, Fang, Hong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419320/
https://ncbi.nlm.nih.gov/pubmed/30871458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-019-2628-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia